Precipio, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 6.27%132.980.0%$2570.66m
BNGOBioNano Genomics, Inc. 2.73%8.270.0%$1690.46m
GILDGilead Sciences, Inc. -1.49%66.981.0%$662.69m
AMGNAmgen, Inc. -0.13%252.031.3%$559.93m
CRSPCRISPR Therapeutics AG -2.46%185.100.6%$485.98m
ALXNAlexion Pharmaceuticals, Inc. 0.08%157.862.0%$476.83m
REGNRegeneron Pharmaceuticals, Inc. -1.25%535.482.7%$473.91m
NVAXNovavax, Inc. -2.12%122.4092.9%$428.82m
ILMNIllumina, Inc. 0.33%404.873.5%$394.29m
VRTXVertex Pharmaceuticals, Inc. 0.82%238.641.9%$360.42m
SRPTSarepta Therapeutics, Inc. 0.17%96.9213.8%$356.59m
BIIBBiogen, Inc. -0.06%270.121.7%$326.66m
BNTXBioNTech SE 2.13%105.430.0%$299.54m
EXASEXACT Sciences Corp. -1.53%148.0719.6%$239.88m
PACBPacific Biosciences of California, Inc. -5.90%36.317.4%$230.80m

Company Profile

Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.